Tunisian Health Minister Mustafa Al-Ferjani recently addressed the issue of drug shortages in the country, stating that they are primarily caused by difficulties in production and supply on an international level. During a parliamentary discussion on the 2027 state budget, Al-Ferjani emphasized the ministry's efforts to implement a national drug strategy, strengthen the role of the National Agency for Medicines, and support local manufacturers.

The minister highlighted that the country has 34 pharmaceutical units that meet 80% of its national needs. However, he noted that there is still room for improvement, particularly in the development of biotechnological drugs and the local production of insulin and cancer medications. This initiative aims to increase the proportion of locally manufactured drugs to 20%.

In response to the current shortages, especially for medications used to treat chronic diseases, the ministry is working on exceptional import licenses. Al-Ferjani also mentioned that the prices of 300 pharmaceutical specialties have been reviewed, with some prices increased or decreased depending on the type of medication and its availability in the market.

To enhance the efficiency of the drug supply chain, the ministry is continuing the digitalization of the system, monitoring stock levels, and improving distribution channels. This approach seeks to ensure a more stable and reliable supply of essential medications to the population.

The implementation of these strategies is part of a broader effort to prioritize the health sector. According to previous statements by the minister, the state is committed to placing the health sector at the forefront of its priorities, reflecting the government's recognition of its importance.

Local drug manufacturing plays a crucial role in this strategy, as it not only helps meet domestic demand but also reduces dependence on international suppliers. The development of biotechnological drugs and the production of critical medications like insulin and cancer drugs locally are expected to significantly enhance the country's pharmaceutical capabilities.

The ongoing efforts to address drug shortages and improve the healthcare system demonstrate the government's commitment to enhancing public health in Tunisia. By focusing on local production, digitalization, and strategic planning, the ministry aims to create a more resilient and self-sufficient healthcare system.

Key points

  • The Tunisian government is working on a national drug strategy to address shortages and improve the healthcare system.
  • Local production of critical medications, such as insulin and cancer drugs, is a key part of this strategy.
  • The ministry is digitalizing the drug supply chain to improve efficiency and reliability.

Reporting sources

Share this story

Written by

SaharaWire Newsroom
SaharaWire

Reporting for SaharaWire from the Nairobi bureau.